Liraglutide studies: 1,219 papers with results
Page 5 of 25
- Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
Jorsal A · European journal of heart failure · 2017
Randomized controlled trial · 3 results
- Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes.
Seino Y · Diabetes research and clinical practice · 2008
Randomized controlled trial · 13 results
- Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes.
Feinglos MN · Diabetic medicine : a journal of the British Diabetic Association · 2005
Randomized controlled trial · 10 results
- Insufficient sleep predicts poor weight loss maintenance after 1 year.
Bogh AF · Sleep · 2023
Randomized controlled trial · 2 results
- Efficacy and safety comparison of add-on therapy with liraglutide, saxagliptin and vildagliptin, all in combination with current conventional oral hypoglycemic agents therapy in poorly controlled Chinese type 2 diabetes.
Li CJ · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2014
Randomized controlled trial · 14 results
- Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12-Month Treatment.
Ikonomidis I · Journal of the American Heart Association · 2020
Randomized controlled trial · 15 results
- Comparison of Dapaglifozin and Liraglutide in Patients with Poorly Controlled Type 2 Diabetes Mellitus: a 24-week, Open, Double-centered, Head to Head Trial.
Jiang J · Endocrine, metabolic & immune disorders drug targets · 2021
Randomized controlled trial · 6 results
- Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial.
Tronieri JS · Obesity facts · 2020
Randomized controlled trial · 1 result
- Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study.
Miyagawa J · Diabetes, obesity & metabolism · 2015
Randomized controlled trial · 15 results
- Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study.
Odawara M · Diabetes, obesity & metabolism · 2016
Randomized controlled trial · 11 results
- Factors associated with successful weight loss after liraglutide treatment for obesity.
Sannaa W · Diabetes, obesity & metabolism · 2023
Randomized controlled trial · 4 results
- Effect of liraglutide treatment on body mass index and weight parameters in children and adolescents with type 2 diabetes: Post hoc analysis of the ellipse trial.
Bensignor MO · Pediatric obesity · 2021
Randomized controlled trial · 4 results
- Evaluating potential predictors of weight loss response to liraglutide in adolescents with obesity: A post hoc analysis of the randomized, placebo-controlled SCALE Teens trial.
Bensignor MO · Pediatric obesity · 2023
Randomized controlled trial · 3 results
- Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial.
Maselli D · Obesity (Silver Spring, Md.) · 2022
Randomized controlled trial · 7 results
- Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes.
Wijkman MO · Journal of clinical hypertension (Greenwich, Conn.) · 2019
Randomized controlled trial · 9 results
- Clinical Efficacy and Safety of Liraglutide and Dapagliflozin on Glucose and Lipid Metabolism and Insulin Function in Patients with Type 2 Diabetes Mellitus.
Ma J · Alternative therapies in health and medicine · 2024
Randomized controlled trial · 17 results
- Analysis of the Efficacy of Polyenyl Phosphatidylcholine in Combination with Liraglutide in Nonalcoholic Fatty Liver Disease and the Effect of Omentin-1 and Vaspin Expression.
Jin Y · Alternative therapies in health and medicine · 2025
Randomized controlled trial · 14 results
- Six-month effects of liraglutide and dapagliflozin on lipid profile, cardiovascular risk, and NT-proBNP levels in patients with metabolic dysfunction-associated steatotic liver disease.
Cherniavskyi V · Wiadomosci lekarskie (Warsaw, Poland : 1960) · 2026
Randomized controlled trial · 19 results
- Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial.
Tronieri JS · International journal of obesity (2005) · 2020
Randomized controlled trial · 13 results
- Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial.
Foghsgaard S · Diabetes, obesity & metabolism · 2024
Randomized controlled trial · 7 results
- Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes.
Dejgaard TF · Diabetes, obesity & metabolism · 2017
Randomized controlled trial · 4 results
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.
Lau DCW · Lancet (London, England) · 2021
Randomized controlled trial · 9 results
- A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial.
Brady EM · Diabetes, obesity & metabolism · 2014
Randomized controlled trial · 7 results
- Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes.
Su Y · Frontiers in endocrinology · 2023
Randomized controlled trial · 15 results
- Growth differentiation factor 15 is not modified after weight loss induced by liraglutide in South Asians and Europids with type 2 diabetes mellitus.
Hoekx CA · Experimental physiology · 2024
Randomized controlled trial · 5 results
- Effects of Liraglutide Combined with Insulin on Oxidative Stress and Serum MCP-1 and NF-kB Levels in Type 2 Diabetes.
Liu X · Journal of the College of Physicians and Surgeons--Pakistan : JCPSP · 2019
Randomized controlled trial · 7 results
- Efficacy and safety of liraglutide in patients with type 2 diabetes mellitus and severe obstructive sleep apnea.
Jiang W · Sleep & breathing = Schlaf & Atmung · 2023
Randomized controlled trial · 6 results
- Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes.
Silver HJ · Diabetes, obesity & metabolism · 2023
Randomized controlled trial · 3 results
- EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES.
Lingvay I · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2019
Randomized controlled trial · 6 results
- Effects of liraglutide or lifestyle interventions combined with other antidiabetic drugs on abdominal fat distribution in people with obesity and type 2 diabetes mellitus evaluated by the energy spectrum ct: A prospective randomized controlled study.
Yu D · Frontiers in endocrinology · 2022
Randomized controlled trial · 4 results
- Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity.
Li CJ · Cardiovascular diabetology · 2012
Randomized controlled trial · 9 results
- Boosting weight loss after conversional Roux-en-Y Gastric Bypass with liraglutide and placebo use. A double-blind-randomized controlled trial.
Hany M · International journal of surgery (London, England) · 2024
Randomized controlled trial · 9 results
- Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes - randomized controlled trial.
Maagensen H · Psychiatry research · 2021
Randomized controlled trial · 3 results
- Proinflammatory biomarkers are associated with prediabetes in patients with schizophrenia.
Møller M · CNS spectrums · 2022
Randomized controlled trial · 1 result
- Liraglutide Improves Forced Vital Capacity in Individuals With Type 2 Diabetes: Data From the Randomized Crossover LIRALUNG Study.
López-Cano C · Diabetes · 2022
Randomized controlled trial · 5 results
- A randomized controlled trial investigating the effect of liraglutide on self-reported liking and neural responses to food stimuli in participants with obesity.
Coppin G · International journal of obesity (2005) · 2023
Randomized controlled trial · 2 results
- Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial.
Frøssing S · Diabetes, obesity & metabolism · 2018
Randomized controlled trial · 12 results
- Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial.
Nylander M · Reproductive biomedicine online · 2017
Randomized controlled trial · 7 results
- Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks.
Kuhadiya ND · Diabetes care · 2016
Randomized controlled trial · 16 results
- Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study.
Elkind-Hirsch KE · Journal of diabetes and its complications · 2020
Randomized controlled trial · 6 results
- Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin.
Vanderheiden A · The Journal of clinical endocrinology and metabolism · 2016
Randomized controlled trial · 9 results
- A cost-controlling treatment strategy of adding liraglutide to insulin in type 2 diabetes.
de Wit HM · The Netherlands journal of medicine · 2017
Randomized controlled trial · 3 results
- Addition of low-dose liraglutide to insulin therapy is useful for glycaemic control during the peri-operative period: effect of glucagon-like peptide-1 receptor agonist therapy on glycaemic control in patients undergoing cardiac surgery (GLOLIA study).
Makino H · Diabetic medicine : a journal of the British Diabetic Association · 2019
Randomized controlled trial · 3 results
- Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes.
Kim SH · Diabetes care · 2013
Randomized controlled trial · 8 results
- Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26-week randomized controlled trial; mechanisms of weight loss.
Ghanim H · Diabetes, obesity & metabolism · 2020
Randomized controlled trial · 15 results
- Effect of liraglutide vs. NPH in combination with metformin on blood glucose fluctuations assessed using continuous glucose monitoring in patients with newly diagnosed type 2 diabetes.
Ma Z · International journal of clinical pharmacology and therapeutics · 2015
Randomized controlled trial · 10 results
- Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride.
Jendle J · Cardiovascular diabetology · 2021
Randomized controlled trial · 4 results
- Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial.
Liao M · Endocrine · 2024
Randomized controlled trial · 16 results
- Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes.
Chen XM · Cardiovascular diabetology · 2018
Randomized controlled trial · 12 results
- Continuous subcutaneous insulin infusion combined with liraglutide reduced glycemic variability and oxidative stress in type 2 diabetes mellitus: a study based on the flash glucose monitoring system.
Li LQ · Endocrine journal · 2019
Randomized controlled trial · 10 results